Vecuronium
Sold as Abbott-vecuronium bromide, Muscuron, Aspen vecuronium
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-Acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
Drag to rotate. Structure from PubChem CID 39765.
Background
Registration
- Applicants
- 3
- Registrations
- 4
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Abbott Laboratories S.A. (Pty) Ltd | Abbott-vecuronium bromide | 4 mg, 10 mg | 350121, 350122 | S4 | None |
| Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) LtdCancelled | Muscuron | 4 mg/vial | 360431 | S4 | PIPIL |
| Pharmacare limited û woodmeadCancelled | Aspen vecuronium | 20 mg | 430325 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Abbott-vecuronium bromide 4 MG EACH 2,0 ml AMPOULE CONTAINS VECURONIUM BROMIDE 4,0 mg | 4 mg | 35012135/17.1/0121 | Registered | S4 | None |
| Abbott-vecuronium bromide 10 MG EACH 10,0 ml VIAL CONTAINS VECURONIUM BROMIDE 10,0 mg | 10 mg | 35012235/17.1/0122 | Registered | S4 | None |
| Muscuron EACH AMPOULE CONTAINS VECURONIUM BROMIDE 4,0 mg | 4 mg/vialInjection | 36043136/17.1/0431Approved 3 January 2024 | Cancelled | S4 | PIPIL |
| Aspen vecuronium 20 MG EACH VIAL CONTAINS VECURONIUM BROMIDE 20,0 mg | 20 mg | 43032543/17.1/0325 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Vecuronium bromide
S4: Vecuronium
Consolidated Schedules 06 July 2026, line 8356
Pharmacological class: Peripherally acting muscle relaxants. (class 17.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Muscuron, Ranbaxy (SA) (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.